Norges Bank’s AbbVie ABBV Stock Holding History

Norges Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,668,761	Closed	-$5.87B	–	7
2025 Q4	$5.87B	Buy	+25,668,761	New	+$5.85B	0.63%	19
2025 Q3	–	Sell	-23,102,037	Closed	-$4.29B	–	7
2025 Q2	$4.29B	Sell	23,102,037 -1,393,787	-6%	-$259M	0.54%	25
2025 Q1	$5.13B	Sell	24,495,824 -599,196	-2%	-$116M	0.72%	19
2024 Q4	$4.46B	Buy	25,095,020 +2,119,873	+9%	+$390M	0.59%	24
2024 Q3	$4.54B	Buy	22,975,147 +496,682	+2%	+$92.7M	0.63%	23
2024 Q2	$3.86B	Buy	22,478,465 +413,696	+2%	+$68.5M	0.58%	26
2024 Q1	$4.02B	Buy	22,064,769 +1,222,746	+6%	+$211M	0.63%	24
2023 Q4	$3.23B	Buy	20,842,023 +385,511	+2%	+$56.2M	0.56%	27
2023 Q3	$3.05B	Buy	20,456,512 +108,987	+0.5%	+$16M	0.62%	23
2023 Q2	$2.74B	Buy	20,347,525 +632,085	+3%	+$92.7M	0.54%	28
2023 Q1	$3.14B	Buy	19,715,440 +945,884	+5%	+$145M	0.69%	20
2022 Q4	$3.03B	Buy	18,769,556 +997,293	+6%	+$153M	0.73%	22
2022 Q3	$2.39B	Buy	17,772,263 +468,878	+3%	+$67.3M	0.63%	23
2022 Q2	$2.65B	Sell	17,303,385 -430,983	-2%	-$65.9M	0.69%	22
2022 Q1	$2.87B	Sell	17,734,368 -236,596	-1%	-$34.4M	0.63%	24
2021 Q4	$2.43B	Sell	17,970,964 -182,537	-1%	-$21.6M	0.5%	32
2021 Q3	$1.96B	Sell	18,153,501 -158,131	-0.9%	-$18.1M	0.43%	39
2021 Q2	$2.06B	Sell	18,311,632 -468,324	-2%	-$52.7M	0.45%	39
2021 Q1	$2.03B	Sell	18,779,956 -547,950	-3%	-$58.6M	0.47%	41
2020 Q4	$2.07B	Buy	19,327,906 +1,141,246	+6%	+$110M	0.48%	37
2020 Q3	$1.59B	Sell	18,186,660 -600,285	-3%	-$56.5M	0.42%	46
2020 Q2	$1.84B	Buy	18,786,945 +3,954,829	+27%	+$348M	0.53%	34
2020 Q1	$1.13B	Sell	14,832,116 -446,907	-3%	-$38.1M	0.4%	50
2019 Q4	$1.35B	Sell	15,279,023 -69,223	-0.5%	-$5.75M	0.38%	44
2019 Q3	$1.16B	Hold	15,348,246	–	–	0.36%	52
2019 Q2	$1.12B	Buy	15,348,246 +336,193	+2%	+$26.4M	0.34%	55
2019 Q1	$1.21B	Buy	15,012,053 +905,635	+6%	+$74.1M	0.39%	44
2018 Q4	$1.3B	Hold	14,106,418	–	–	0.48%	34
2018 Q3	$1.33B	Sell	14,106,418 -185,902	-1%	-$17.6M	0.43%	36
2018 Q2	$1.32B	Buy	14,292,320 +435,453	+3%	+$42.5M	0.45%	36
2018 Q1	$1.31B	Buy	13,856,867 +127,644	+0.9%	+$14M	0.47%	36
2017 Q4	$1.33B	Buy	13,729,223 +21,170	+0.2%	+$2M	0.48%	35
2017 Q3	$1.22B	Sell	13,708,053 -210,115	-2%	-$16M	0.46%	37
2017 Q2	$1.01B	Sell	13,918,168 -403,301	-3%	-$27.1M	0.4%	41
2017 Q1	$933M	Buy	14,321,469 +1,163,008	+9%	+$73.1M	0.38%	44
2016 Q4	$824M	Sell	13,158,461 -32,786	-0.2%	-$2M	0.36%	47
2016 Q3	$795M	Sell	13,191,247 -334,371	-2%	-$21.6M	0.38%	48
2016 Q2	$837M	Sell	13,525,618 -246,183	-2%	-$15M	0.4%	46
2016 Q1	$787M	Sell	13,771,801 -390,019	-3%	-$21.7M	0.39%	48
2015 Q4	$839M	Buy	14,161,820 +168,244	+1%	+$9.69M	0.42%	48
2015 Q3	$761M	Buy	13,993,576 +275,399	+2%	+$17.9M	0.4%	49
2015 Q2	$922M	Buy	13,718,177 +1,482,093	+12%	+$96.8M	0.46%	42
2015 Q1	$716M	Sell	12,236,084 -100,968	-0.8%	-$6.1M	0.35%	52
2014 Q4	$807M	Buy	12,337,052 +429,175	+4%	+$27.1M	0.41%	45
2014 Q3	$688M	Sell	11,907,877 -11,415,099	-49%	-$634M	0.37%	48
2014 Q2	$1.32B	Buy	23,322,976 +11,679,928	+100%	+$613M	0.36%	52
2014 Q1	$598M	Hold	11,643,048	–	–	0.34%	54
2013 Q4	$615M	Sell	11,643,048 -873,945	-7%	-$43M	0.35%	53
2013 Q3	$560M	Sell	12,516,993 -23,052	-0.2%	-$1.02M	0.33%	59
2013 Q2	$518M	Buy	+12,540,045	New	+$548M	0.32%	58

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank's ABBV Position: Q1 2026 in Review

Norges Bank sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 25,668,761 shares — an estimated $5.87B sold.

Norges Bank first reported a position in ABBV in Q2 2013 and held it in 50 quarters. The position peaked at $5.87B in Q4 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Norges Bank reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
Norges Bank sold 25,668,761 AbbVie shares in Q1 2026, an estimated $5.87B.
Norges Bank first reported a position in AbbVie in Q2 2013 and held it in 50 quarters.
Norges Bank's AbbVie position peaked at $5.87B in Q4 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.